Preview

Russian Journal of Cardiology

Advanced search

Left ventricular function in mitral valve prolapse and severe mitral regurgitation

https://doi.org/10.15829/1560-4071-2013-1-37-42

Abstract

Aim. To assess systolic left ventricular (LV) function in patients with mitral valve prolapse (MVP) and different morphological MV disorders.

 

Material and methods. The study included 233 patients (mean age 53,8±12,9 years), who underwent MV surgery due to MPV and severe mitral regurgitation (MR) at the V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology in 2009-2011. The resected MV segments underwent a pathomorphological examination; preoperative strain and strain rate were assessed with the speckle tracking method (EchoPAC’08).

 

Results. Based on the pathomorphological data, Barlow’s disease was registered in 60 patients (25,8%), and fibroelastic deficiency in 173 patients (74,2%). The preintervention echocardiography did not demonstrate any significant difference between the two groups in terms of preoperative MR volume (70,5±9,6 ml vs. 71,6±8,5 ml, p=0,40), systolic LV function (ejection fraction 52,7±6,6% vs. 52,0±7,4%; p=0,53) and diastolicLV function (E/e’ 12,2±3,9 vs. 12,8±4,2; p=0,35). Despite no difference in ejection fraction, the Barlow’s disease group demonstrated a significant reduction inLV longitudinal systolic (-13,5±2,2% vs. -16,6±2,3%; p=0,008) and diastolic strain (1,14±0,20 s-1 vs. 1,34±0,18 s-1; p=0,04), as well as in strain rate (-0.89±0,15 s-1 vs. -1,14±0,15 s-1; p=0,002), compared to the fibroelastic deficiency group.

 

Conclusion. Patients with Barlow’s disease, compared to patients with fibroelastic deficiency, have a lower preoperative LV systolic function, which might affect the postoperative long-term survival rates. The deteriorated LV function could be due to the damage of endocardial and intramyocardial extracellular matrix in Barlow’s disease.

About the Authors

E. G. Malev
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation


G. I. Kim
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation


L. B. Mitrofanova
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation


M. Yu. Omelchenko
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation


E. V. Zemtsovsky
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation


References

1. Enriquez-Sarano M, Akins CW, Vahanian A. Mitral regurgitation. Lancet 2009;373: 1382–94.

2. Adams D. H., Rosenhek R., Falk V. Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J 2010; 31 (16):1958–66.

3. Carpentier A., Chauvaud S., Fabiani J. N., et al. Reconstructive surgery of mitral valve incompetence: ten-year appraisal. J Thorac Cardiovasc Surg 1980; 79:338–48.

4. Anyanwu A. C., Adams D. H. Etiologic classification of degenerative mitral valve disease: Barlow’s disease and fibroelastic deficiency. Semin Thorac Cardiovasc Surg 2007; 19 (2):90–6.

5. Fornes P., Heudes D., Fuzellier J. F., et al. Correlation between clinical and histologic patterns of degenerative mitral valve insufficiency: a histomorphometric study of 130 excised segments. Cardiovasc Pathol 1999; 8:81–92.

6. Barlow J. B., Pocock W. A. The significance of late systolic murmurs and mid-late systolic clicks. Md State Med J 1963; 12:76–7.

7. Carpentier A. F., Pellerin M., Fuzellier J. F., et al. Extensive calcification of the mitral valve anulus: pathology and surgical management. J Thorac Cardiovasc Surg 1996; 111:718–29.

8. Pellerin D., Brecker S., Veyrat C. Degenerative mitral valve disease with emphasis on mitral valve prolapse. Heart 2002; 88 Suppl 4: iv20–8.

9. Bonow R. O., Carabello B. A., Kanu C., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation 2006; 114 (5): e84–231.

10. Starling M. R, Kirsh MM, Montgomery DG, et al. Impaired left ventricular contractile function in patients with long-term mitral regurgitation and normal ejection fraction. J Am Coll Cardiol 1993; 22:239–50.

11. Lancellotti P., Cosyns B., Zacharakis D., et al. Importance of left ventricular longitudinal function and functional reserve in patients with degenerative mitral regurgitation: assessment by two-dimensional speckle tracking. J Am Soc Echocardiogr 2008; 21 (12):1331–6.

12. Marciniak A., Sutherland G. R., Marciniak M., et al. Prediction of postoperative left ventricular systolic function in patients with chronic mitral regurgitation undergoing valve surgery – the role of deformation imaging. Eur J Cardiothorac Surg 2011; 40 (5):1131–7.

13. Mor-Avi V., Lang R. M., Badano L. P., et al. Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography. Eur J Echocardiogr 2011 Mar; 12 (3):167–205.

14. Kozlov P. S., Malev E. G., Prokudina M. N., et al. Strain and strain rate – novel technique for quantification of regional myocardial function. Arterial hypertension 2010; 16 (2):215–7. Russian (Козлов П. С., Малев Э. Г., Прокудина М. Н. и соавт. Деформация и скорость деформации – новые возможности количественной оценки регионарной функции миокарда. Артериальная гипертензия 2010; 16 (2):215–7).

15. Mascle S., Schnell F., Thebault C., et al. Predictive value of global longitudinal strain in a surgical population of organic mitral regurgitation. J Am Soc Echocardiogr 2012; 25 (7):766–72.

16. Ben Zekry S., Nagueh S. F., Little S. H., et al. Comparative accuracy of two- and threedimensional transthoracic and transesophageal echocardiography in identifying mitral valve pathology in patients undergoing mitral valve repair: initial observations. Journal of the American Society of Echocardiography 2011; 24 (10):1079–85.

17. Lancellotti P., Moura L., Pierard L. A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 2010; 11 (4):307–32.

18. Lang R. M., Bierig M., Devereux R. B., et al. Recommendations for chamber quantification. Eur J Echocardiogr 2006; 7:79–108.

19. Devereux R. B., Alonso D. R., Lutas E. M., et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450–8.

20. Nagueh S. F., Appleton C. P., Gillebert T. C., et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. Eur J Echocardiogr 2009; 10:165–93.

21. Mitrofanova L. B. Valvular heart disease. New view on the etiology, pathogenesis and morphology. SPb.: OOO “Meditsinskoye izdatelstvo”, 2007. 192 p. Russian (Митрофанова Л. Б. Клапанные пороки сердца. Новый взгляд на этиологию, патогенез и морфологию. Спб.: ООО «Медицинское издательство», 2007. 192 с).

22. Dalen H., Thorstensen A., Aase S. A., et al. Segmental and global longitudinal strain and strain rate based on echocardiography of 1266 healthy individuals: the HUNT study in Norway. Eur J Echocardiogr. 2010; 11 (2):176–83.

23. Oxborough D., Batterham A. M., Shave R., et al. Interpretation of two-dimensional and tissue Doppler-derived strain (epsilon) and strain rate data: is there a need to normalize for individual variability in left ventricular morphology? Eur J Echocardiogr. 2009 Jul; 10 (5):677–82.

24. De Agustín J. A., Pérez de Isla L., Núñez-Gil I. J., et al. Assessment of myocardial deformation: Predicting medium-term left ventricular dysfunction after surgery in patients with chronic mitral regurgitation. Rev Esp Cardiol 2010; 63 (5):544–53.

25. França H. H. An interpretation – mitral valve prolapse syndrome. Arq Bras Cardiol 2000; 74 (5):453–8.

26. Morales A. R., Romanelli R., Boucek R. J., et al. Myxoid heart disease: An assessment of extravalvular cardiac pathology in severe mitral valve prolapse. Human Pathology 1992; 23 (2):129–37.

27. Pope A. J., Sands G. B., Smaill B. H., et al. Three-dimensional transmural organization of perimysial collagen in the heart. Am J Physiol Heart Circ Physiol 2008 Sep; 295 (3): H1243–52.

28. Kiotsekoglou A., Saha S., Moggridge J. C., et al. Impaired biventricular deformation in Marfan syndrome: a strain and strain rate study in adult unoperated patients. Echocardiography 2011; 28 (4):416–30.

29. Eckman P. M., Hsich E, Rodriguez E. R., et al. Impaired systolic function in Loeys-Dietz syndrome: a novel cardiomyopathy? Circ Heart Fail 2009; 2 (6):707–8.

30. Malev E., Zemtsovsky E., Pshepiy A., et al. Cardiomyopathy in Mitral Valve Prolapse. Journal of Cardiac Failure 2012; 18 (8): S30.

31. Klein G., Schaefer A., Hilfiker-kleiner D., et al. Increased collagen deposition and diastolic dysfunction but preserved myocardial hypertrophy after pressure overload in mice lacking PKCepsilon. Circ Res. 2005; 96 (7):748–55.

32. Meyer A., Wang W., Qu J., et al. Platelet TGF-

33. Saracini C., Bolli P., Sticchi E., et al. Polymorphisms of genes involved in extracellular matrix remodeling and abdominal aortic aneurysm. J Vasc Surg. 2012 Jan; 55 (1):171– 9.e2.

34. Matos-Souza J. R., Fernandes-Santos M. E., Hoehne EL, et al. Isolated mitral valve prolapse is an independent predictor of aortic root size in a general population. Eur J Echocardiogr 2010 Apr; 11 (3):302–5.


Review

For citations:


Malev E.G., Kim G.I., Mitrofanova L.B., Omelchenko M.Yu., Zemtsovsky E.V. Left ventricular function in mitral valve prolapse and severe mitral regurgitation. Russian Journal of Cardiology. 2013;(1):37-42. (In Russ.) https://doi.org/10.15829/1560-4071-2013-1-37-42

Views: 1381


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)